CN101269215B - 一种糖蛋白激素组合物 - Google Patents

一种糖蛋白激素组合物 Download PDF

Info

Publication number
CN101269215B
CN101269215B CN2008100374254A CN200810037425A CN101269215B CN 101269215 B CN101269215 B CN 101269215B CN 2008100374254 A CN2008100374254 A CN 2008100374254A CN 200810037425 A CN200810037425 A CN 200810037425A CN 101269215 B CN101269215 B CN 101269215B
Authority
CN
China
Prior art keywords
fsh
variant
glycoprotein hormones
lactose
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN2008100374254A
Other languages
English (en)
Chinese (zh)
Other versions
CN101269215A (zh
Inventor
季晓铭
高霄梁
季斌
严惠敏
洪云海
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Techwell Biopharmaceutical Co Ltd
Original Assignee
Shanghai Techwell Biopharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Techwell Biopharmaceutical Co Ltd filed Critical Shanghai Techwell Biopharmaceutical Co Ltd
Priority to CN2008100374254A priority Critical patent/CN101269215B/zh
Publication of CN101269215A publication Critical patent/CN101269215A/zh
Priority to JP2009117421A priority patent/JP5143784B2/ja
Priority to PCT/CN2009/071806 priority patent/WO2009138042A1/zh
Priority to KR1020090042756A priority patent/KR101095647B1/ko
Application granted granted Critical
Publication of CN101269215B publication Critical patent/CN101269215B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pregnancy & Childbirth (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
CN2008100374254A 2008-05-15 2008-05-15 一种糖蛋白激素组合物 Active CN101269215B (zh)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CN2008100374254A CN101269215B (zh) 2008-05-15 2008-05-15 一种糖蛋白激素组合物
JP2009117421A JP5143784B2 (ja) 2008-05-15 2009-05-14 糖タンパク質ホルモン組成物
PCT/CN2009/071806 WO2009138042A1 (zh) 2008-05-15 2009-05-15 一种糖蛋白激素组合物
KR1020090042756A KR101095647B1 (ko) 2008-05-15 2009-05-15 당단백질 호르몬 조성물

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2008100374254A CN101269215B (zh) 2008-05-15 2008-05-15 一种糖蛋白激素组合物

Publications (2)

Publication Number Publication Date
CN101269215A CN101269215A (zh) 2008-09-24
CN101269215B true CN101269215B (zh) 2011-03-23

Family

ID=40003607

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2008100374254A Active CN101269215B (zh) 2008-05-15 2008-05-15 一种糖蛋白激素组合物

Country Status (4)

Country Link
JP (1) JP5143784B2 (ja)
KR (1) KR101095647B1 (ja)
CN (1) CN101269215B (ja)
WO (1) WO2009138042A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102038649B (zh) * 2009-10-20 2015-10-14 丽珠医药集团股份有限公司 尿促卵泡刺激素冻干粉针剂及其制备方法
KR101483165B1 (ko) * 2009-12-22 2015-01-15 샹하이 테크웰 바이오파마슈티컬 컴퍼니, 리미티드 인간폐경성선자극호르몬의 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1206302B (it) * 1987-06-26 1989-04-14 Serono Cesare Ist Ricerca Ormone follicolo-stimolante urinario
IE64738B1 (en) * 1990-03-20 1995-09-06 Akzo Nv Stabilized gonadotropin containing preparations
IT1250075B (it) * 1991-12-18 1995-03-30 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti gonadotropine.
US5656597A (en) * 1993-04-28 1997-08-12 Akzo Nobel N.V. Lyospheres comprising gonadotropin
PT1169349E (pt) * 1999-04-16 2007-06-18 Inst Massone S A Composições de gonadotropina de altamente purificada e processo para a sua preparação
AU2003217367B2 (en) * 2002-02-08 2005-09-08 Alkermes Controlled Therapeutics, Inc. Polymer-based compositions for sustained release
BRPI0409532B8 (pt) * 2003-04-02 2021-05-25 Ares Trading Sa composição farmacêutica líquida, artigo de fabricação, método de fabricação de composição farmacêutica e método de fabricação de artigo de fabricação

Also Published As

Publication number Publication date
CN101269215A (zh) 2008-09-24
KR101095647B1 (ko) 2011-12-19
KR20090119741A (ko) 2009-11-19
JP2009275045A (ja) 2009-11-26
JP5143784B2 (ja) 2013-02-13
WO2009138042A1 (zh) 2009-11-19

Similar Documents

Publication Publication Date Title
CN1273187C (zh) 稳定性提高的无锌或低锌胰岛素制剂
TW518235B (en) A gonadotropin-containing pharmaceutical composition with improved stability on prolong storage
US7879805B2 (en) High temperature stable peptide formulation
KR100221123B1 (ko) 안정화된 고나도트로핀을 함유하는 제제
RU2236250C2 (ru) Фармацевтическая композиция, содержащая гормон роста, аминокислоту и неионогенный детергент
US20100069292A1 (en) Insulin with a basal release profile
CN101912600B (zh) 改善胰岛素在溶液中稳定性的方法
AU738413B2 (en) Human growth hormone-containing aqueous pharmaceutical composition
EP0082731A1 (en) The use of peptides as medicaments
CN107249620A (zh) 一种包含glp‑1类似物的药物制剂及其制备方法
CN102552883B (zh) 一种多肽复合物、药物组合物、其制备方法和应用
CN101269215B (zh) 一种糖蛋白激素组合物
CN1823768A (zh) 西咪替丁冻干组合物
CN106309358A (zh) 含有人甲状旁腺激素的药物组合物及其制备方法与用途
CN102100908B (zh) 一种蛋白质组合物
CN101851287B (zh) 一种高比活绝经期促性腺素及其制备方法和用途
JP7399382B2 (ja) 組換えヒト副甲状腺ホルモンの安定性を向上させるための製剤
EP3287140A1 (en) Nerve growth factor composition and powder injection
CN104870469A (zh) 药物组合物
US6153581A (en) Drug for recovering renal function
JP5456045B2 (ja) サブユニットを殆ど含まない糖タンパク質組成物及びその製造方法
WO2011156476A2 (en) Insulin with a basal release profile
CN102309745B (zh) 一种卵泡刺激素冻干针剂
JP2023553106A (ja) 改善された凍結乾燥製剤
EP3287141B1 (en) Nerve growth factor composition and injection powder

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant